Skip to main content
Top
Published in: Supportive Care in Cancer 11/2006

01-11-2006 | Supportive Care International

Financial and family burden associated with cancer treatment in Ontario, Canada

Authors: Christopher J. Longo, Margaret Fitch, Raisa B. Deber, A. Paul Williams

Published in: Supportive Care in Cancer | Issue 11/2006

Login to get access

Abstract

Goals of work

To determine the financial and family resources burden associated with the treatment of cancer. A questionnaire was developed to determine the direct monthly “out-of-pocket costs” (OOPC), the indirect costs, and the associated perceived family burden.

Materials and methods

A self-administered questionnaire using a quota sample from five cancer clinics in Ontario, Canada was given to 282 cancer patients (74 breast, 70 colorectal, 68 lung, and 70 prostate). Monthly OOPC were obtained for: drugs, home care, homemaking, complementary and alternative medicines, vitamins and supplements, family care, travel, parking, accommodations, devices, and others. The questionnaire asked if OOPC for treatment were a burden, and if others took time from work to provide caregiving.

Main results

The mean monthly OOPC was $213, with an additional $372 related to imputed travel costs. For those patients who responded that the burden was “significant” (16.5%), their OOPC was $452. In the case of patients responding that their burden was “unmanageable” (3.9%), their OOPC was $544. The survey showed that 35.6% of patients required others to take time from work and this was higher in the under-65 category. The mean number of days lost from work in the previous 30 days for these caregivers was 7 days.

Conclusions

These results suggest the financial burden is problematic for 20% of this sample. The caregivers’ lost time from work influence this burden, and for 36% of this sample, it amounts to one third of their working days in any given month. Policies and programs to address these gaps are needed.
Literature
1.
go back to reference Alter DA, Naylor CD, Austin P et al (1999) Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341(18):1359–1367CrossRefPubMed Alter DA, Naylor CD, Austin P et al (1999) Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341(18):1359–1367CrossRefPubMed
2.
go back to reference Alter DA, Iron K, Austin PC et al (2004) Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada. JAMA 291(9):1100–1107CrossRefPubMed Alter DA, Iron K, Austin PC et al (2004) Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada. JAMA 291(9):1100–1107CrossRefPubMed
3.
go back to reference Barer ML, Evans RG, Stoddart GL (1979) Controlling health care costs by direct charges to patients: snare or delusion? Ontario Economic Council occasional paper no. 10. Ontario Economic Council, Toronto Barer ML, Evans RG, Stoddart GL (1979) Controlling health care costs by direct charges to patients: snare or delusion? Ontario Economic Council occasional paper no. 10. Ontario Economic Council, Toronto
4.
go back to reference Birenbaum LK (1992) Terminal care costs in childhood cancer. Pediatr Nursing 18:285–288 Birenbaum LK (1992) Terminal care costs in childhood cancer. Pediatr Nursing 18:285–288
5.
go back to reference Browne GB, Arpin K, Corey P, Fitch M, Gafni A (1990) Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care 28(1):43–58CrossRefPubMed Browne GB, Arpin K, Corey P, Fitch M, Gafni A (1990) Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care 28(1):43–58CrossRefPubMed
6.
go back to reference Carlson LE, Bultz BD (2003) Cancer distress screening: needs, models and methods. J Psychosom Res 55:403–409CrossRefPubMed Carlson LE, Bultz BD (2003) Cancer distress screening: needs, models and methods. J Psychosom Res 55:403–409CrossRefPubMed
7.
go back to reference Doran E, Robertson J, Rolfe I et al (2004) Patient co-payments and use of prescription medicines. Aust N Z J Public Health 28(1):62–67PubMed Doran E, Robertson J, Rolfe I et al (2004) Patient co-payments and use of prescription medicines. Aust N Z J Public Health 28(1):62–67PubMed
8.
go back to reference Dunlop S, Coyte PC, McIssac W (2000) Socio-economic status and the utilization of physicians’ services: results from the Canadian National Population Health Survey. Soc Sci Med 51:123–133CrossRefPubMed Dunlop S, Coyte PC, McIssac W (2000) Socio-economic status and the utilization of physicians’ services: results from the Canadian National Population Health Survey. Soc Sci Med 51:123–133CrossRefPubMed
9.
go back to reference Evans C, Crawford B (1999) Patient self-reports in pharmacoeconomic studies: their use and impact on study validity. Pharmacoeconomics 15(3):241–256CrossRefPubMed Evans C, Crawford B (1999) Patient self-reports in pharmacoeconomic studies: their use and impact on study validity. Pharmacoeconomics 15(3):241–256CrossRefPubMed
11.
go back to reference Guidry JJ, Aday LA, Zhang D, Winn RJ (1998) Cost considerations as potential barriers to cancer treatment. Cancer Pract 6(3):182–187CrossRefPubMed Guidry JJ, Aday LA, Zhang D, Winn RJ (1998) Cost considerations as potential barriers to cancer treatment. Cancer Pract 6(3):182–187CrossRefPubMed
12.
go back to reference Houts PS, Lipton A, Harvey HA, Martin B, Simmonds MA, Dixon RH, Longo S, Andrews T, Gordon RA, Meloy J, Hoffman SL (1984) Non-medical costs to patients and their families associated with outpatient chemotherapy. Cancer 53(11):2388–2392CrossRefPubMed Houts PS, Lipton A, Harvey HA, Martin B, Simmonds MA, Dixon RH, Longo S, Andrews T, Gordon RA, Meloy J, Hoffman SL (1984) Non-medical costs to patients and their families associated with outpatient chemotherapy. Cancer 53(11):2388–2392CrossRefPubMed
13.
go back to reference Huang J, Zhou S, Groome P et al (2001) Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19(1):137–144PubMed Huang J, Zhou S, Groome P et al (2001) Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 19(1):137–144PubMed
14.
go back to reference Johnson RE, Goodman RM, Hornbrok MC et al (1997) The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 35:1119–1131CrossRefPubMed Johnson RE, Goodman RM, Hornbrok MC et al (1997) The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 35:1119–1131CrossRefPubMed
15.
go back to reference Moore K (1998) Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncol Nurs Forum 25(9):1615–1622PubMed Moore K (1998) Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncol Nurs Forum 25(9):1615–1622PubMed
16.
go back to reference Organization for Economic Co-operation and Development (OECD) (2004) Organization for Economic Co-operation and Development (OECD) health data. A comparative analysis of 30 OECD countries (CD-ROM). OECD, Paris, France Organization for Economic Co-operation and Development (OECD) (2004) Organization for Economic Co-operation and Development (OECD) health data. A comparative analysis of 30 OECD countries (CD-ROM). OECD, Paris, France
17.
go back to reference Paszat LF, MacKillop WJ, Groome PA et al (1998) Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 21(3):125–134PubMed Paszat LF, MacKillop WJ, Groome PA et al (1998) Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 21(3):125–134PubMed
18.
go back to reference Public Health Agency of Canada (1998) Economic burden of illness in Canada. November 2002 Public Health Agency of Canada (1998) Economic burden of illness in Canada. November 2002
19.
go back to reference Riley GF, Potosky AL, Lubitz JD et al (1995) Medicare payments from diagnosis to death for aged cancer patients by state at diagnosis. Med Care 33:828–841CrossRefPubMed Riley GF, Potosky AL, Lubitz JD et al (1995) Medicare payments from diagnosis to death for aged cancer patients by state at diagnosis. Med Care 33:828–841CrossRefPubMed
20.
go back to reference Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ (1996) Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 49(9):989–995CrossRefPubMed Roberts RO, Bergstralh EJ, Schmidt L, Jacobsen SJ (1996) Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 49(9):989–995CrossRefPubMed
21.
go back to reference Ryan M, Birch S (1991) Charging for heath care: evidence on the utilization of NHS prescribed drugs. Soc Sci Med 33:681–687CrossRefPubMed Ryan M, Birch S (1991) Charging for heath care: evidence on the utilization of NHS prescribed drugs. Soc Sci Med 33:681–687CrossRefPubMed
22.
go back to reference Soumerai SB, McLaughlin TJ, Ross-Degnan D et al (1994) Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 331:650–655CrossRefPubMed Soumerai SB, McLaughlin TJ, Ross-Degnan D et al (1994) Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 331:650–655CrossRefPubMed
23.
go back to reference Spitzer WO, Roberts RS, Delmore T (1976) Nurse practitioners in primary care. V. Development of the utilization and financial index to measure effects of their deployment. CMAJ 114(12):1099–1102 Spitzer WO, Roberts RS, Delmore T (1976) Nurse practitioners in primary care. V. Development of the utilization and financial index to measure effects of their deployment. CMAJ 114(12):1099–1102
24.
go back to reference Stommel M, Given CW, Given BA (1993) The cost of cancer home care to families. Cancer 71(5):1867–1874CrossRefPubMed Stommel M, Given CW, Given BA (1993) The cost of cancer home care to families. Cancer 71(5):1867–1874CrossRefPubMed
25.
go back to reference Tamblyn R, Laprise R, Hanley JA et al (2001) Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285(4):421–429CrossRefPubMed Tamblyn R, Laprise R, Hanley JA et al (2001) Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285(4):421–429CrossRefPubMed
26.
go back to reference Weissman JS, Levin K, Chasan-Taber S, Massagli MP, Seage GR, Scampini L (1996) The validity of self-reported health-care utilization by AIDS patients. AIDS 10(7):775–783PubMedCrossRef Weissman JS, Levin K, Chasan-Taber S, Massagli MP, Seage GR, Scampini L (1996) The validity of self-reported health-care utilization by AIDS patients. AIDS 10(7):775–783PubMedCrossRef
Metadata
Title
Financial and family burden associated with cancer treatment in Ontario, Canada
Authors
Christopher J. Longo
Margaret Fitch
Raisa B. Deber
A. Paul Williams
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0088-8

Other articles of this Issue 11/2006

Supportive Care in Cancer 11/2006 Go to the issue

Forthcoming Meetings

Forthcoming Meetings

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine